184 related articles for article (PubMed ID: 15467833)
1. CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.
Abou-Rjaily GA; Lee SJ; May D; Al-Share QY; Deangelis AM; Ruch RJ; Neumaier M; Kalthoff H; Lin SH; Najjar SM
J Clin Invest; 2004 Oct; 114(7):944-52. PubMed ID: 15467833
[TBL] [Abstract][Full Text] [Related]
2. Shc and CEACAM1 interact to regulate the mitogenic action of insulin.
Poy MN; Ruch RJ; Fernstrom MA; Okabayashi Y; Najjar SM
J Biol Chem; 2002 Jan; 277(2):1076-84. PubMed ID: 11694516
[TBL] [Abstract][Full Text] [Related]
3. CEACAM1 regulates insulin clearance in liver.
Poy MN; Yang Y; Rezaei K; Fernström MA; Lee AD; Kido Y; Erickson SK; Najjar SM
Nat Genet; 2002 Mar; 30(3):270-6. PubMed ID: 11850617
[TBL] [Abstract][Full Text] [Related]
4. Regulation of insulin action by CEACAM1.
Najjar SM
Trends Endocrinol Metab; 2002 Aug; 13(6):240-5. PubMed ID: 12128284
[TBL] [Abstract][Full Text] [Related]
5. The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity.
Fournès B; Sadekova S; Turbide C; Létourneau S; Beauchemin N
Oncogene; 2001 Jan; 20(2):219-30. PubMed ID: 11313949
[TBL] [Abstract][Full Text] [Related]
6. Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice.
Dai T; Abou-Rjaily GA; Al-Share' QY; Yang Y; Fernström MA; Deangelis AM; Lee AD; Sweetman L; Amato A; Pasquali M; Lopaschuk GD; Erickson SK; Najjar SM
J Biol Chem; 2004 Oct; 279(43):45155-61. PubMed ID: 15316023
[TBL] [Abstract][Full Text] [Related]
7. Insulin acutely decreases hepatic fatty acid synthase activity.
Najjar SM; Yang Y; Fernström MA; Lee SJ; Deangelis AM; Rjaily GA; Al-Share QY; Dai T; Miller TA; Ratnam S; Ruch RJ; Smith S; Lin SH; Beauchemin N; Oyarce AM
Cell Metab; 2005 Jul; 2(1):43-53. PubMed ID: 16054098
[TBL] [Abstract][Full Text] [Related]
8. Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance.
Al-Share QY; DeAngelis AM; Lester SG; Bowman TA; Ramakrishnan SK; Abdallah SL; Russo L; Patel PR; Kaw MK; Raphael CK; Kim AJ; Heinrich G; Lee AD; Kim JK; Kulkarni RN; Philbrick WM; Najjar SM
Diabetes; 2015 Aug; 64(8):2780-90. PubMed ID: 25972571
[TBL] [Abstract][Full Text] [Related]
9. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1.
Huang S; Kaw M; Harris MT; Ebraheim N; McInerney MF; Najjar SM; Lecka-Czernik B
Bone; 2010 Apr; 46(4):1138-45. PubMed ID: 20044046
[TBL] [Abstract][Full Text] [Related]
10. Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
Stern N; Markel G; Arnon TI; Gruda R; Wong H; Gray-Owen SD; Mandelboim O
J Immunol; 2005 Jun; 174(11):6692-701. PubMed ID: 15905509
[TBL] [Abstract][Full Text] [Related]
11. The CEACAM1-L glycoprotein associates with the actin cytoskeleton and localizes to cell-cell contact through activation of Rho-like GTPases.
Sadekova S; Lamarche-Vane N; Li X; Beauchemin N
Mol Biol Cell; 2000 Jan; 11(1):65-77. PubMed ID: 10637291
[TBL] [Abstract][Full Text] [Related]
12. The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells.
Sundberg U; Beauchemin N; Obrink B
J Cell Sci; 2004 Mar; 117(Pt 7):1091-104. PubMed ID: 14970258
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen cell adhesion molecule 1 directly associates with cytoskeleton proteins actin and tropomyosin.
Schumann D; Chen CJ; Kaplan B; Shively JE
J Biol Chem; 2001 Dec; 276(50):47421-33. PubMed ID: 11595750
[TBL] [Abstract][Full Text] [Related]
14. Multiple mitogenic pathways in pancreatic cancer cells are blocked by a truncated epidermal growth factor receptor.
Matsuda K; Idezawa T; You XJ; Kothari NH; Fan H; Korc M
Cancer Res; 2002 Oct; 62(19):5611-7. PubMed ID: 12359775
[TBL] [Abstract][Full Text] [Related]
15. The critical role of residues 43R and 44Q of carcinoembryonic antigen cell adhesion molecules-1 in the protection from killing by human NK cells.
Markel G; Gruda R; Achdout H; Katz G; Nechama M; Blumberg RS; Kammerer R; Zimmermann W; Mandelboim O
J Immunol; 2004 Sep; 173(6):3732-9. PubMed ID: 15356119
[TBL] [Abstract][Full Text] [Related]
16. Characterization of recombinant soluble carcinoembryonic antigen cell adhesion molecule 1.
Schumann D; Huang J; Clarke PE; Kirshner J; Tsai SW; Schumaker VN; Shively JE
Biochem Biophys Res Commun; 2004 May; 318(1):227-33. PubMed ID: 15110777
[TBL] [Abstract][Full Text] [Related]
17. Cell adhesion molecule CEACAM1 associates with paxillin in granulocytes and epithelial and endothelial cells.
Ebrahimnejad A; Flayeh R; Unteregger G; Wagener C; Brümmer J
Exp Cell Res; 2000 Nov; 260(2):365-73. PubMed ID: 11035932
[TBL] [Abstract][Full Text] [Related]
18. Ceacam1 deletion causes vascular alterations in large vessels.
Najjar SM; Ledford KJ; Abdallah SL; Paus A; Russo L; Kaw MK; Ramakrishnan SK; Muturi HT; Raphael CK; Lester SG; Heinrich G; Pierre SV; Benndorf R; Kleff V; Jaffa AA; Lévy E; Vazquez G; Goldberg IJ; Beauchemin N; Scalia R; Ergün S
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E519-29. PubMed ID: 23800882
[TBL] [Abstract][Full Text] [Related]
19. CEACAM1 in Liver Injury, Metabolic and Immune Regulation.
Horst AK; Najjar SM; Wagener C; Tiegs G
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30314283
[TBL] [Abstract][Full Text] [Related]
20. Two variable regions in carcinoembryonic antigen-related cell adhesion molecule1 N-terminal domains located in or next to monoclonal antibody and adhesion epitopes show evidence of recombination in rat but not in human.
Comegys MM; Lin SH; Rand D; Britt D; Flanagan D; Callanan H; Brilliant K; Hixson DC
J Biol Chem; 2004 Aug; 279(33):35063-78. PubMed ID: 15184366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
